Company Performance Metrics
EMP Genetech conducts development and production of recombinant proteins as a service provider for research departments in industry and academia. For production HEK293 (hn embryonic kidney) cells are being used. These cells are distinguished for the expression of glycosilated, correctly processed and modified proteins. The expressed proteins show
excellent bioactivity compared to other expression systems. The biomolecules are produced in serum free culture medium of safe origin. EMP Genetech offers all working steps from cloning of the GOI to chromatographic purification of the produced
protein. There are developed stable cell lines of high productivity. These are cultivated as suspension cell cultures in stirred bioreactors usually in a continous mode. The expression product is purified from cell supernatant or cell extract by classical column chromatographic methods. The bioactivity
will be analysed by enzymatic or cell assays.
